Statement from the REMAP-CAP trial
Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms working together to test the...
COVID-19
The COVID-19 category provides evidence-informed insight into the ongoing pandemic and its impacts on health, society and healthcare systems. It covers research updates, long-term effects, vaccines and policy discussions, helping readers understand developments and implications as the landscape continues to evolve.
Migrants and refugees say COVID-19 has dramatically worsened their lives
Migrants and refugees say COVID-19 has dramatically worsened their lives: The COVID-19 pandemic has had a highly negative impact on the living and working conditions...
Reducing coronavirus spread during dental procedures
Coronavirus spread during dental procedures could be reduced with slower drill rotation: Researchers from Imperial College London and King’s College London have found that careful selection...
Lecture from Government Chief Scientific Adviser, Sir Patrick Vallance
Sir Patrick Vallance delivers Hammersmith and White City Distinguished Lecture: Government Chief Scientific Adviser, Sir Patrick Vallance, spoke on science in government and shared insights...
Lasting Power of Attorney and the Covid vaccine
Do I have the right to refuse the Covid vaccine on behalf of a relative? The requirement for an Lasting Power of Attorney (LPA) to...
Update on The University of Queensland COVID-19 vaccine
Friday, 11th December, 2020: The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that...
Less than 50% willing to get a COVID-19 vaccine
Less than half of people currently willing to get a COVID-19 vaccine, international survey suggests: A new report on the public’s attitudes towards coronavirus vaccines has...
People with rare autoimmune diseases at increased risk of dying during Covid-19
A new study, led by experts from the University of Nottingham, has shown that people with rare autoimmune rheumatic diseases are at a greater risk...
Lung disease diagnosis wait times
Lung disease diagnosis wait times: 1 in 3 people with lung disease end up waiting longer than six months for a diagnosis. New research released...
COVID-19: cancer diagnosis and care
COVID-19: cancer diagnosis and care: Covid-19 may have changed the way people have been diagnosed with cancer and how they receive care – new study...
